Clinical Trials Directory

Trials / Completed

CompletedNCT04177238

Effects of Oral Fruit Concentrate Supplementation on Cardiometabolic Parameters.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
University of Central Lancashire · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. Anthocyanins, found in high quantities in both tart cherries and blueberries are powerful antioxidants, that are potentially capable of improving cardiometabolic dysfunction. However, to date, no research has explored the cardiometabolic responses to tart cherry and blueberry supplementation. Therefore, the primary purpose of the proposed investigation is to test the ability of oral tart cherry and blueberry supplementation to improve cardiometabolic parameters in healthy individuals.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFruit concentrate - either cherry or blueberryFruit (cherry or blueberry concentrate) supplement from a company named Active-Edge (https://active-edge.co.uk/).

Timeline

Start date
2020-01-21
Primary completion
2022-02-05
Completion
2022-08-05
First posted
2019-11-26
Last updated
2022-11-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04177238. Inclusion in this directory is not an endorsement.